
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
What is the most likely cause of epigastric pain or discomfort in patients who have not undergone any investigations?
Patients who present with predominant epigastric pain or discomfort but who have not undergone any investigations are likely to have what condition?
a. Dyspepsia
b. GERD
c. Celiac disease
d. None of the above






